

| Numéro de catalogue | HB058818 |
|---|---|
| Description |
HEK293T Human CD142/F3/TF Stable Cell Line (HB058818) is a stable cell line expressing CD142/F3/TF. Engineered for consistent, high-level target expression in research applications.
Highlights
|
| Numéro d'accès | P13726 |
| Applications | FCM |
| Espèce hôte | HEK293T |
| Espèces | Human |
| Cible | CD142/F3/TF |
| Propriétés | Growth Properties: Adherent; Selection Marker: Puromycin (1 μg/mL) |
| Stabilité et stockage | Frozen in liquid nitrogen. |
| Spécifications | 1 vial contains at least 2×10^6 cells in 1 mL Freeze Medium |
| Contexte | Tissue factor (CD142/F3) is a ~33 kDa protein. Initiates blood coagulation by forming a complex with circulating factor VII or VIIa. The [TF:VIIa] complex activates factors IX or X by specific limited proteolysis. TF plays a role in normal hemostasis by initiating the cell-surface assembly and propagation of the coagulation protease cascade. CD142 is the therapeutic target of tisotumab vedotin (Tivdak). |

Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an anti-human CD142 monoclonal antibody at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.




Contactez-nous pour les devis personnalisés, les demandes en gros et tout autre problème.
Courrier : [email protected]


+86-027-65523339
Bâtiment C, No. 666, Rue Shendunsi, Wuhan, 430206, Chine
中文
English
한국어
日本語
Español
Français
Русский